IRIS - Res&Arch Institutional Research Information System - Research & Archive

MOMI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.523
AS - Asia 1.600
EU - Europa 1.533
SA - Sud America 264
Continente sconosciuto - Info sul continente non disponibili 120
AF - Africa 36
OC - Oceania 1
Totale 6.077
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.449
SG - Singapore 708
IE - Irlanda 271
IT - Italia 260
UA - Ucraina 250
CN - Cina 226
RU - Federazione Russa 212
HK - Hong Kong 202
VN - Vietnam 200
BR - Brasile 195
SE - Svezia 123
DE - Germania 104
FR - Francia 84
FI - Finlandia 82
GB - Regno Unito 64
BD - Bangladesh 63
KR - Corea 40
CA - Canada 33
TR - Turchia 32
IN - India 28
AR - Argentina 26
CO - Colombia 14
PK - Pakistan 14
ES - Italia 12
UZ - Uzbekistan 12
MX - Messico 10
ZA - Sudafrica 10
BE - Belgio 9
IQ - Iraq 9
AT - Austria 8
CH - Svizzera 8
EC - Ecuador 8
JP - Giappone 8
MA - Marocco 8
NL - Olanda 8
NI - Nicaragua 7
PL - Polonia 7
VE - Venezuela 7
LB - Libano 6
MY - Malesia 6
CL - Cile 5
CR - Costa Rica 5
ID - Indonesia 5
IR - Iran 5
JO - Giordania 5
PH - Filippine 5
RO - Romania 5
TT - Trinidad e Tobago 5
CZ - Repubblica Ceca 4
IL - Israele 4
KE - Kenya 4
PE - Perù 4
SA - Arabia Saudita 4
EE - Estonia 3
GT - Guatemala 3
KZ - Kazakistan 3
LT - Lituania 3
NP - Nepal 3
SN - Senegal 3
TN - Tunisia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BG - Bulgaria 2
BO - Bolivia 2
DZ - Algeria 2
EG - Egitto 2
GR - Grecia 2
HU - Ungheria 2
PA - Panama 2
PR - Porto Rico 2
RS - Serbia 2
SV - El Salvador 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MQ - Martinica 1
MZ - Mozambico 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
SY - Repubblica araba siriana 1
Totale 5.959
Salva come PNG Salva come JPEG
Città #
Singapore 495
Chandler 326
Dublin 266
San Jose 223
Hong Kong 201
Ashburn 151
San Mateo 146
Jacksonville 139
Santa Clara 95
Dong Ket 83
Boardman 80
Council Bluffs 80
Perugia 80
Altamura 77
Beijing 76
Princeton 65
Medford 63
Moscow 60
Lawrence 57
Lauterbourg 52
Ann Arbor 51
Wilmington 51
New York 45
Ho Chi Minh City 39
Seoul 39
Los Angeles 35
Andover 29
Hanoi 29
Des Moines 27
Munich 27
The Dalles 27
Piscataway 21
Saint Petersburg 21
São Paulo 21
Helsinki 18
Dearborn 17
Frankfurt am Main 15
Dallas 14
Brooklyn 13
North Bergen 12
Phoenix 12
San Paolo di Civitate 12
Woodbridge 12
Izmir 11
Norwalk 10
Shanghai 10
Turku 10
Brussels 9
Da Nang 9
London 9
Toronto 9
Denver 8
Falkenstein 8
Johannesburg 8
Tokyo 8
Ankara 7
Montreal 7
Naples 7
Orem 7
Rome 7
San Francisco 7
Stockholm 7
Houston 6
Madrid 6
Managua 6
Nuremberg 6
Poplar 6
Tashkent 6
Atlanta 5
Baghdad 5
Belo Horizonte 5
Bogotá 5
Buffalo 5
Charlotte 5
Columbus 5
Curitiba 5
Milan 5
New Delhi 5
Ottawa 5
Amsterdam 4
Auburn Hills 4
Campo Grande 4
Chennai 4
Delhi 4
Falls Church 4
Haiphong 4
Islamabad 4
Kuala Lumpur 4
Lahore 4
Medellín 4
Olomouc 4
Roubaix 4
San José 4
Santo André 4
Amelia 3
Amman 3
Aracaju 3
Brasília 3
Bắc Ninh 3
Can Tho 3
Totale 3.729
Salva come PNG Salva come JPEG
Nome #
Reperfusion of cerebral artery thrombosis by the GPIb-VWF blockade with the Nanobody ALX-0081 reduces brain infarct size in guinea pigs. 147
Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. 144
Interaction with damaged vessel wall in vivo in humans induces platelets to express CD40L resulting in endothelial activation. No effect of aspirin intake. 137
Contribution of matrix metalloproteinase 2 to joint destruction in group B Streptococcus-induced murine arthritis. 136
Nitric oxide and its antithrombotic action on the cardiovascular system 135
Platelets are essential for leukocyte recruitment in allergic inflammation. 134
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 126
A novel mechanism regulating human platelet activation by MMP-2-mediated PAR1 biased signaling 126
Defective platelet beta-N-Acetyl hexosaminidase content and release in chronic myeloproliferative disorders 123
Allergen induces the migration of platelets to lung tissue in allergic asthma. 122
RhoA signaling through platelet P2Y1 receptor controls leukocyte recruitment in allergic mice. 118
Nitric oxide-donating aspirin (NCX 4016): an overview of its pharmacological properties and clinical perspectives. 118
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. 116
Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation 116
A novel nitric oxide-releasing statin derivative exerts and antiplatelet/antithrombotic activity and inhibits tissue factor expression. 116
Mechanisms of thrombocytopenia in platelet-type von Willebrand disease 114
AB0952 Intra-articular low molecular weight hyaluronate reduces platelet influx and matrix metalloproteinase-2 levels in synovial fluid of patients with knee osteoarthritis 112
Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis. 111
Platelets contribute to the accumulation of matrix metalloproteinase type 2 in synovial fluid in osteoarthritis 110
A dichotomy in platelet activation: Evidence of different functional platelet responses to inflammatory versus haemostatic stimuli 110
Anti-platelet treatments in cancer: Basic and clinical research 110
Anti-platelet therapy: phosphodiesterase inhibitors. 109
Prevalence of hemostatic alterations in patients with recurrent spontaneous subconjunctival hemorrhage 108
Matrix metalloproteinases and peripheral arterial disease. 104
Matrix metalloproteinase-2 enhances platelet deposition on collagen under flow conditions 102
Established and new antiplatelet therapies 99
Matrix metalloproteinase-2 of human carotid atherosclerotic plaques promotes platelet activation. Correlation with ischaemic events. 98
Highly Active Antiretroviral Therapy-related Mechanisms of Endothelial and Platelets Function Alterations 98
Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome. 96
HYPERGLYCEMIA-INDUCED PLATELET ACTIVATION IN TYPE 2 DIABETES MELLITUS IS RESISTANT TO ASPIRIN BUT NOT TO A NITRIC OXIDE-DONATING AGENT. 95
Platelets release matrix metalloproteinase-2 in the coronary circulation of patients with acute coronary syndromes: possible role in sustained platelet activation. 93
Visualization of nitric oxide production by individual platelets during adhesion in flowing blood. 93
Nitroaspirin plus clopidogrel versus aspirin plus clopidogrel against platelet thromboembolism and intimal thickening in mice 91
Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders. 91
Endothelium, venous thromboembolism and ischaemic cardiovascular events. 90
Chemotaxis and phagocytosis 89
Platelet-targeted pharmacologic treatments as anti-cancer therapy 89
Prevention of pulmonary thromboembolism by NCX 4016, a nitric oxide-releasing aspirin. 88
Endogenous nitric oxide acts as a natural antithrombotic agent in vivo by inhibiting platelet aggregation in the pulmonary vasculature. 88
A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression. 87
Platelet Priming. 84
Low molecular weight heparins prevent thrombin-induced thromboembolism in mice despite low antithrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition. 84
Impaired thrombin-induced platelet activation and thrombus formation in mice lacking the Ca(2+)-dependent tyrosine kinase Pyk2. 83
Nitric oxide-enhancing or -releasing agents as antithrombotic drugs. 83
Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. 80
Trombocitopenia da eparina nel paziente dializzato 78
Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function. 77
Matrix metalloproteinase-2 on activated platelets triggers endothelial PAR-1 initiating atherosclerosis 77
Involvement of platelets in experimental mouse trypanosomiasis: evidence of mouse platelet cytotoxicity against Trypanosoma equiperdum. 75
NCX4016: a novel antithrombotic agent. 75
NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties. 74
Platelet dysfunction in platelet-type von Willebrand disease due to the constitutive triggering of the Lyn-PECAM1 inhibitory pathway 72
Potentiation and priming of platelet activation: a potential target for antiplatelet therapy. 71
Platelets in respiratory disorders and inflammatory conditions. 68
Matrix Metalloproteinases and Platelet Function 68
Platelets are necessary for airway wall remodeling in a murine model of chronic allergic inflammation. 67
Interactions of gallic acid, resveratrol, quercetin and aspirin at the platelet cyclooxygenase-1 level. Functional and modelling studies. 65
PCSK9 in Haemostasis and Thrombosis: Possible Pleiotropic Effects of PCSK9 Inhibitors in Cardiovascular Prevention 62
Platelets and chemotaxis. 61
Role of Platelets in the Pathogenesis of Osteoarthritis and Biological Effects of Hyaluronic Acid: in Vivo and in Vitro Study 60
The effect of defibrotide on thromboembolism in the pulmonary vasculature of mice and rabbits and in the cerebral vasculature of rabbits 59
Dicer Neosynthesis Regulates Platelet Reactivity: A Mechanism Altered in Type 2 Diabetes 55
Stimulation of platelet nitric oxide production by nebivolol prevents thrombosis. 55
Stroke prevention: from available antiplatelet drugs to novel molecular targets. 55
Totale 6.077
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.060
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.060
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022373 0 0 0 26 9 10 7 147 7 19 69 79
2022/20231.002 70 232 10 71 78 104 0 48 338 3 30 18
2023/2024381 19 42 18 5 2 4 99 9 46 12 77 48
2024/2025768 6 78 34 28 107 37 29 56 157 32 142 62
2025/20261.886 117 116 111 231 282 161 336 72 209 137 92 22
2026/2027488 35 47 119 287 0 0 0 0 0 0 0 0
Totale 6.077